— Know what they know.
Not Investment Advice
Also trades as: TATVA.BO (BSE) · $vol 0M

TATVA.NS NSE

Tatva Chintan Pharma Chem Limited
1W: +0.8% 1M: +8.7% 3M: +39.5% YTD: +45.8% 1Y: +67.0% 3Y: +3.7%
₹1,750.00 ($18.17)
-34.20 (-1.92%)
 
NSE · Basic Materials · Chemicals - Specialty · Tech Score Strong Buy · Power 61 · ₹40.9B mcap · 6M float · 2.06% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹40.9B ($425.1M)
52W Range1026.5-1880
Volume64,285
Avg Volume124,594
Beta0.42
Dividend₹2.00
Analyst Ratings
No analyst coverage
Company Info
CEOChintan Nitinkumar Shah
Employees793
SectorBasic Materials
IndustryChemicals - Specialty
IPO Date2021-07-29
Plot No. 353
Vadodara, GU 390010
IN
91 75 7484 8533
About Tatva Chintan Pharma Chem Limited

Tatva Chintan Pharma Chem Limited, an Indian-based enterprise, specializes in the production and distribution of diverse specialty chemicals. Its extensive product range encompasses essential components like structure-directing agents crucial for zeolite synthesis, phase transfer catalysts, and electrolyte salts vital for supercapacitor batteries. Furthermore, the company supplies pharmaceutical active pharmaceutical ingredients (APIs), agrochemical formulations, and various other specialized chemical products, including intermediates, disinfectants, catalytic agents, and solvents. Beyond manufacturing, Tatva Chintan engages in the trading of specialty chemicals and offers quaternary compounds (quats) and bulk drug substances. The firm's clientele spans a broad spectrum of sectors, such as the automotive, petrochemical, pharmaceutical, agricultural chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrance industries. Its global reach extends to approximately 25 nations, where its products are exported. Established in 1996, Tatva Chintan Pharma Chem Limited maintains its corporate headquarters in Vadodara, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms